Cardiopulmonary Events of the Elderly (≥75 Years) during Clazosentan Therapy after Subarachnoid Hemorrhage: A Retrospective Study from a Tertiary Stroke Center in Japan

Clazosentan has been shown to prevent vasospasm and reduce mortality in patients after aneurysmal subarachnoid hemorrhage (SAH) and has been approved for clinical use in Japan; however, its systemic events in the elderly (aged ≥ 75 years) have not been well-documented. Here, we report serious/intole...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tatsushi Mutoh, Hiroaki Aono, Wataru Seto, Takehiro Kimoto, Ryota Tochinai, Junta Moroi, Tatsuya Ishikawa
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-01-01
Colecção:	Medicina
Assuntos:	clazosentan cerebral vasospasm elderly subarachnoid hemorrhage systemic events
Acesso em linha:	https://www.mdpi.com/1648-9144/60/1/185
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!